Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-12-19

Clinical Trial Update: Hyaluronic Acid 0.2% Application Enhanced Chronic Periodontitis Treatment in Non-surgical Phase [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on topical hyaluronic acid 0.2% as an adjunct in non-surgical treatment of chronic periodontitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hyaluronic Acid 0.2% (hyaluronic acid)

Snippet

Sponsor: University of Medicine and Pharmacy at Ho Chi Minh City | Conditions: Chronic Periodontitis, Hyaluronic Acid | Phase 4 | Status: COMPLETED